Robati Shahin, Saab Wiam, Durán-Retamal Montserrat, Saab Wael, Theodorou Efstathios, Cawood Suzanne, Serhal Paul, Seshadri Srividya
Institute for Women's Health, Faculty of Population Health Sciences, University College London, Lebanon, United Kingdom.
Department of Obstetrics and Gynaecology, The American University of Beirut Medical Centre, Beirut, Lebanon.
J Reprod Infertil. 2020 Oct-Dec;21(4):283-290. doi: 10.18502/jri.v21i4.4333.
The advent of ovarian stimulation within an fertilization (IVF) cycle has resulted in modifying the physiology of stimulated cycles and has helped optimize pregnancy outcomes. In this regard, the importance of progesterone (P4) elevation at time of human chorionic gonadotrophin (hCG) administration within an IVF cycle has been studied over several decades. Our study aimed to evaluate the association of P4 levels at time of hCG trigger with live birth rate (LBR), clinical pregnancy rate (CPR) and miscarriage rate (MR) in fresh IVF or IVF-ICSI cycles.
This was a retrospective cohort study (n=170) involving patients attending the Centre for Reproductive and Genetic Health (CRGH) in London. The study cohort consisted of women undergoing controlled ovarian stimulation using GnRH antagonist or GnRH agonist protocols. Univariate and multiple logistic regression analyses were used to evaluate the association of clinical outcomes. Differences were considered statistically significant if p≤0.05.
As serum progesterone increased, a decrease in LBR was observed. Following multivariate logistical analyses, LBR significantly decreased with P4 thresholds of 4.0 (OR 0.42, 95% CI:0.17-1.0) and 4.5 (OR 0.35, 95% CI:0.12-0.96).
P4 levels are important in specific groups and the findings were statistically significant with a P4 threshold value between 4.0-4.5 . Therefore, it seems logical to selectively measure serum P4 levels for patients who have ovarian dysfunction or an ovulatory cycles and accordingly prepare the individualized management packages for such patients.
体外受精(IVF)周期中卵巢刺激的出现改变了刺激周期的生理状况,并有助于优化妊娠结局。在这方面,几十年来一直在研究IVF周期中注射人绒毛膜促性腺激素(hCG)时孕酮(P4)升高的重要性。我们的研究旨在评估新鲜IVF或IVF-ICSI周期中hCG触发时P4水平与活产率(LBR)、临床妊娠率(CPR)和流产率(MR)之间的关联。
这是一项回顾性队列研究(n = 170),研究对象为伦敦生殖与遗传健康中心(CRGH)的患者。研究队列包括使用GnRH拮抗剂或GnRH激动剂方案进行控制性卵巢刺激的女性。采用单因素和多因素逻辑回归分析来评估临床结局的关联。如果p≤0.05,则认为差异具有统计学意义。
随着血清孕酮水平升高,观察到活产率下降。多因素逻辑分析后,当P4阈值为4.0(OR 0.42,95%CI:0.17 - 1.0)和4.5(OR 0.35,95%CI:0.12 - 0.96)时,活产率显著下降。
P4水平在特定人群中很重要,研究结果在P4阈值为4.0 - 4.5时具有统计学意义。因此,对于卵巢功能障碍或排卵周期异常的患者,选择性地检测血清P4水平并据此为其制定个体化管理方案似乎是合理的。